We're proud to be part of the first CancerX Moonshot Accelerator program! 🌟 A special thanks to CancerX Moonshot and our amazing partner Massive Bio. Together, we will leverage AI-enabled tools to enhance access to next-generation sequencing and provide vital mental health support for patients seeking clinical trials. 🔬🤝 This collaboration will make a real difference in the lives of cancer patients and their families, helping them navigate their treatment journeys with greater ease and confidence.💪❤️ #CancerX #MikaHealth #MassiveBio #CancerMoonshot #DigitalHealth
Earlier this year, Mika was one of 16 startup companies selected for the first cohort of the CancerX Accelerator program, which helped them attract scale-up partners like MassiveBio, a CancerX member organization. By working with Massive Bio, Mika is providing AI-enabled tools to improve access to next-generation sequencing and mental health support for patients seeking clinical trials involving investigational cancer therapies. This partnership is helping patients and their families accelerate their access to important information that can connect them to the right clinical trials while improving their experience managing the process—both strongly tied to CancerX and the Cancer Moonshot goals. Are you a CancerX member who has also benefited from a partnership with another organization as a result of this initiative? We want to hear from you! Please email [email protected] with your story.